logo

Biotechnology & Drugs News

Share

Roche: EMA Approves Shorter 90-minute Gazyvaro Infusion Time In Patients With Follicular Lymphoma

ObsEva Announces Strategic Relationship With Syneos Health To Commercialize Linzagolix

VTv Therapeutics Says Mechanistic Study Of TTP399 In Patients With Type 1 Diabetes Primary Endpoint

CureVac To Withdraw 1st-generation COVID-19 Vaccine Candidate, CVnCoV From Approval Process With EMA